Read More

MDMA therapy gets support from prominent research group as FDA weighs action

As an August deadline for the U.S. Food and Drug Administration looms regarding approval for psychedelic therapies, a coalition of well-known scientific researchers took it upon itself to publicize its support for midomafetamine (MDMA)-based treatment for patients with post-traumatic stress disorder. In an online consensus statement, 23 medical doctors and …